…against the advice of its own expert panel, ensuring another windfall for Big Pharma at the expense of patients and taxpayers. The FDA has approved the first new Alzheimer’s drug in years—a drug which will reportedly cost more than $56,000 per year. The FDA’s treatment of this drug—which is incredibly expensive and comes with real
against the advice of its own expert panel, ensuring another windfall for Big Pharma at the expense of patients and taxpayers. The FDA has approved the first new Alzheimer’s drug in years—a drug which will reportedly cost more than $56,000 per year. The FDA’s treatment of this drug—which is incredibly expensive and comes with real dangers—is in stark contrast to the skepticism and attacks that…
